• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《中国病理生理杂志》 >丙氨酰-谷氨酰胺下调口服他克莫司损伤的肠黏膜组织中iNOS和TNF -α的表达

丙氨酰-谷氨酰胺下调口服他克莫司损伤的肠黏膜组织中iNOS和TNF -α的表达

         
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

AIM: To investigate the effects of alanyl - glutamine ( Ala -Gln) on expression of iNOS and TNF- α in injured intestinal mucosa induced by oral tacrolimus (FK506). METHODS: Twenty -four BALB/c mice were randomized to receive orally 0.2 mL of normal saline solution ( group Ⅰ ), 0.2 mL of FK506 in a dose of 0.1 mg/kg ( group Ⅱ ) or 1.0 mg/kg (group Ⅲ), and orally high -dose FK506 (0.2 mL, 1.0 mg/kg) plus intraperitoneal injection of Ala -Gln (0.5 g/kg )(group Ⅳ ),respectively. Damages of intestinal mucosa were determined by pathological examination.Intestinal mucosal permeability was analysed by FITC - dextran fluorescence assay. Expression of iNOS and TNF - α in intestine was detected by RT - PCR and Western blotting. RESULTS: Severe damage on the villi and increased intestinal permeability were observed in high - dose FK506 treated mice according to scanning electron microscopy and FITC - dextran flux respectively. The erosion and increased intestinal permeability were significantly alleviated by Ala - Gln treatment. Transcription of iNOS mRNA and TNF - α mRNA, which was up - regulated in high - dose FK506 treated group,was also markedly down- regulated in mice combined with Ala- Gln- treatment. A significantly increased expression of iNOS and TNF - α protein was found in the high - dose FK506 treated mice, while small amounts of these proteins were identified in the Ala - Gln - treated group. CONCLUSION: FK506 could induce a significant impairment of intestinal mucosa morphologically, which might be associated with up - regulated expression of iNOS and TNF - α in small intestinal mucosa. Subsequently, the intestinal permeability is increased. Ala - Gln has a strong protective effect on FK506 - induced intestinal barrier dysfunction, probably relates to the down - regulation of iNOS and TNF - α expression.%目的:研究丙氨酰-谷氨酰胺(Ala-Gln)对口服FK506损伤的肠黏膜组织中iNOS和TNF-α分子表达的影响.方法:BALB/c小鼠24只,随机分成对照组、FK506低剂量组、FK506高剂量组及Ala-Gln治疗组,分别给以0.2 mL生理盐水、FK506 0.1 mg/kg、1.0 mg/kg灌胃和FK506 1.0 mg/kg灌胃及丙氨酰-谷氨酰胺0.5 g/kg腹腔注射.隔天给药,6周后采集回肠标本.HE染色和扫描电镜观察肠黏膜组织形态学改变;FITC-dextran(FD4)检测肠黏膜通透性;RT-PCR检测小肠黏膜iNOS和TNF-α mRNA的表达情况;Western blotting检测iNOS和TNF-α蛋白表达水平.结果:FK506高剂量组的肠黏膜对FD4的通透性明显增加,扫描电镜示小肠绒毛破坏明显,而Ala-Gln治疗组小肠绒毛破坏减轻,对FD4的通透性下降;FK506高剂量组小肠黏膜iNOS mRNA和TNF-α mRNA表达增强,而Ala-Gln治疗组表达则明显下调;iNOS和TNF-α蛋白表达水平的变化与此一致.结论:FK506通过上调iNOS和TNF-α的表达对小肠黏膜产生损伤,使小肠壁的通透性增加.Ala-Gln对FK506所致的肠黏膜屏障功能损伤具有保护作用,该作用可能与下调iNOS和TNF-α的表达有关.

著录项

  • 来源
    《中国病理生理杂志》 |2007年第5期|939-944|共6页
  • 作者

    万云乐; 吴丽花; 余松峰; 金晶; 柯庆宏; 郑树森;

  • 作者单位

    中山大学第二附属医院肝胆外科,器官移植中心,广东,广州,510120;

    浙江大学医学院附属第一医院外科研究所,多器官联合移植重点实验室,浙江,杭州,310003;

    浙江大学医学院附属第一医院外科研究所,多器官联合移植重点实验室,浙江,杭州,310003;

    浙江大学医学院附属第一医院外科研究所,多器官联合移植重点实验室,浙江,杭州,310003;

    浙江大学医学院附属第一医院外科研究所,多器官联合移植重点实验室,浙江,杭州,310003;

    浙江大学医学院附属第一医院外科研究所,多器官联合移植重点实验室,浙江,杭州,310003;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 病理生理学;
  • 关键词

    他克莫司; 肠黏膜; 丙氨酰-谷氨酰胺; 一氧化氮合酶; 肿瘤坏死因子;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号